Titre:
  • Omalizumab Therapy for Mast Cell-Mediator Symptoms in Patients with ISM, CM, MMAS, and MCAS
Auteur:Lemal, Richard; Fouquet, Guillemette; Terriou, Louis; Vaes, Melanie; Livideanu, Cristina Bulai; Frenzel, Laurent; Barete, Stéphane; Canioni, Danielle; Lhermitte, Ludovic Loup L.; Rossignol, Julien; Arock, Michel; Dubreuil, Patrice; Lortholary, Olivier; Hermine, Olivier
Informations sur la publication:Journal of Allergy and Clinical Immunology: In Practice
Statut de publication:Publié, 2019
Sujet CREF:Pathologie maladies infectieuses
Mots-clés:IgE
Mast cell disorders
Mastocytosis
Omalizumab
Note générale:SCOPUS: ar.j
DecretOANoAutActif
Langue:Anglais
Identificateurs:urn:issn:2213-2198
info:doi/10.1016/j.jaip.2019.03.039
info:pii/S2213219819303228
info:scp/85065097529
info:pmid/30954641